Upcoming Talk by Dr. Chalmers aka Dr. Bronchiectasis

​Save the date! Join Bronchiectasis/NTM Info & Research and Running on Air for an insightful webinar with Professor James Chalmers on the latest updates from the European Bronchiectasis Workshop & Forum on Respiratory Tract Infections.

Meet Prof. James D. Chalmers: A Leading Authority on Bronchiectasis

When it comes to advancing bronchiectasis care, few names are as influential as Professor James D. Chalmers. As the Asthma and Lung UK Chair of Respiratory Research at the University of Dundee, Prof. Chalmers has dedicated his career to improving outcomes for individuals living with bronchiectasis.

He is best known for his leadership in the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC), an international research network that has transformed our understanding of bronchiectasis, and for serving as Chief Editor of the European Respiratory Journal.

With over 350 peer-reviewed publications, Prof. Chalmers has made critical contributions to our understanding of the pathophysiology, diagnosis, and treatment of bronchiectasis. He is a key author of the European Respiratory Society (ERS) guidelines for the management of adult bronchiectasis, which offer clinicians trusted, evidence-based recommendations for bronchiectasis care.

Professor Chalmers' Contribution to the Aspen Study

Chalmers' groundbreaking work includes leading innovative clinical trials such as the ​ASPEN study involving Brensocatib, a potential first-in-class therapy targeting neutrophilic inflammation. For details on this trial, see the clinical trial registry entry for Brensocatib (NCT04594369). These studies are helping pave the way for precision medicine in bronchiectasis.

Contribution to International Guidelines and Standards of Care

Prof. Chalmers has also chaired and contributed to major international guidelines, including the 2017 ERS guidelines and the latest European Lung Foundation bronchiectasis management recommendations. His efforts continue to standardize care and improve quality of life for bronchiectasis patients around the world.

Thanks to experts like Prof. Chalmers, the future of bronchiectasis care is looking brighter—with innovative therapies, patient-centered guidelines, and individualized treatment strategies leading the way.

#Bronchiectasis Awareness  #BronchiectasisResearch  #JamesChalmers  #ERSGuidelines  #PrecisionMedicine  #Brensocatib  #RespiratoryHealth 

✨Date: February 27 2025
✨Time: 1 PM EDT